News

A fourth season of the show about a fish-out-of-water soccer coach has been announced by Sudeikis, the co-creator and Big ...
From pig ears to "white sauce" to the legendary ribs that fed the civil rights movement, Alabama has a diverse and tangy ...
From pig ears to "white sauce" to the legendary ribs that fed the civil rights movement, Alabama has a diverse and tangy culinary history. Here are the best places to get a taste.
The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio. Verve’s innovative gene-editing technology, which permanently ...
Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic jolt that could accelerate the city’s ambitions to become a national ...
INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...
Fair Value Estimate for Eli Lilly. With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per share, an increase from $620 as a result ...
B eing first to market with a drug can be crucial. Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved in its home country ...
Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an overreaction to GLP-1 news.
Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year. The ...